← SynDRA
E-7820
SynDRA canonical compound SYN0039532 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ITGA2 |
|---|
| Mechanism of action | angiogenesis inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- RBM39 BINDER
- angiogenesis inhibitor
- ITGA2 INHIBITOR
Cross-references
Synonyms
- E7820
- ER-68203-00
- E 7820
- UNII-TVH5K7949N
- TVH5K7949N
- 3-cyano-N-(3-cyano-4-methyl-1H-indol-7-yl)benzenesulfonamide
- N-(3-cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzene-sulfonamide
- NSC-719239
- N-(3-cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzenesulfonamide
- Benzenesulfonamide, 3-cyano-N-(3-cyano-4-methyl-1H-indol-7-yl)-
- LWGUASZLXHYWIV-UHFFFAOYSA-N
- AC1L52N5
- ZINC8704
- SCHEMBL1581157
- DTXSID20183142
- BCP25835
- EX-A1818
- 3-Cyano-N-(3-cyano-4-methyl-1H-indole-7-yl)benzensulfonamide
- NSC719239
- AKOS032944953
- CS-6075
- RefChem:920775
- DTXCID30105633
- O6M
- MFCD09833234
- ER68203-00
- orb1302862
- SCHEMBL31237463
- GTPL14234
- GLXC-10196
- BDBM50635842
- EBC-75115
- NSC777573
- s6628
- NSC-777573
- SB16542
- NCGC00475733-03
- AC-36189
- BS-16799
Look up E-7820 in the interactive SynDRA portal →